Argenx (ARGX)
(Delayed Data from NSDQ)
$499.67 USD
-16.51 (-3.20%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $499.41 -0.26 (-0.05%) 7:58 PM ET
1-Strong Buy of 5 1
F Value F Growth A Momentum F VGM
Price, Consensus and EPS Surprise
ARGX 499.67 -16.51(-3.20%)
Will ARGX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ARGX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ARGX
Best Momentum Stocks to Buy for July 31st
New Strong Buy Stocks for July 31st
ARGX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Argenx (ARGX) Upgraded to Buy: Here's What You Should Know
Is Argenx (ARGX) Stock Outpacing Its Medical Peers This Year?
Cartesian (RNAC) MG Study Meets Goals, Stock Down on Other Updates
Other News for ARGX
Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), IGC Pharma (IGC) and Fresenius Medical Care AG & Co. KGaA (GB:0H9X)
Northrop Grumman To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
Argenx price target raised by $25 at Baird, here's why
Kepler Cheuvreux gets more bullish on Argenx, upgrades shares
Argenx price target raised by $41 at Wedbush, here's why